Kaplan–Meier survival analysis revealed that patients bearing tumors with higher CXCL9 levels did not show a difference in overall survival compared with those bearing tumors with lower CXCL9 levels, suggesting that CXCL9 is not a good independent prognostic factor in osteosarcoma. The gene discussed is CXCL9; the disease is osteosarcoma.